International Patent: USE OF U6-PROMOTER-BASED CDC6SHRNA IN PREPARATION OF DRUG FOR TREATING SOLID TUMORS

GENEVA, Aug. 21 -- QINGDAO ARTAI GENE CO., LTD. filed a patent application (CN2025/082969) for “USE OF U6-PROMOTER-BASED CDC6SHRNA IN PREPARATION OF DRUG FOR TREATING SOLID TUMORS”. With publication no. WO/2026/170598, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/7105

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....